Do analysts rate USNA or HLF?

Herbalife has a consensus price target of $17.80, indicating a potential upside of 48.25%. Given Herbalife's stronger consensus rating and higher probable upside, analysts clearly believe Herbalife is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Herbalife 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43

Does the media refer more to USNA or HLF?

In the previous week, Herbalife had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 5 mentions for Herbalife and 4 mentions for USANA Health Sciences. Herbalife's average media sentiment score of 0.79 beat USANA Health Sciences' score of 0.52 indicating that Herbalife is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Herbalife 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer USNA or NATR?

Nature's Sunshine Products has a consensus target price of $35.00, indicating a potential upside of 71.32%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Nature's Sunshine Products 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00

Does the media refer more to USNA or NATR?

In the previous week, USANA Health Sciences had 3 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 4 mentions for USANA Health Sciences and 1 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.89 beat USANA Health Sciences' score of 0.52 indicating that Nature's Sunshine Products is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nature's Sunshine Products 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend USNA or NUS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Nu Skin Enterprises 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts prefer USNA or MED?

Medifast has a consensus price target of $12.00, suggesting a potential upside of 17.03%. Given Medifast's stronger consensus rating and higher probable upside, analysts clearly believe Medifast is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Medifast 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Does the media prefer USNA or MED?

In the previous week, Medifast had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 5 mentions for Medifast and 4 mentions for USANA Health Sciences. Medifast's average media sentiment score of 1.21 beat USANA Health Sciences' score of 0.52 indicating that Medifast is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medifast 1 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer VERU or USNA?

Veru currently has a consensus price target of $23.00, indicating a potential upside of 866.39%. Given Veru's stronger consensus rating and higher possible upside, equities research analysts plainly believe Veru is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veru 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has preferable valuation & earnings, VERU or USNA?

USANA Health Sciences has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veru $16.89M 2.26 -$22.73M -$0.89 N/A USANA Health Sciences $925.26M 0.44 $10.76M $0.47 46.48

Does the media favor VERU or USNA?

In the previous week, USANA Health Sciences had 3 more articles in the media than Veru. MarketBeat recorded 4 mentions for USANA Health Sciences and 1 mentions for Veru. Veru's average media sentiment score of 0.94 beat USANA Health Sciences' score of 0.52 indicating that Veru is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veru 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive USANA Health Sciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

USANA Health Sciences (USNA) Competitors

$21.84 -0.81 (-3.56%)

Closing price 03:59 PM Eastern

Extended Trading

$21.77 -0.07 (-0.34%)

As of 04:10 PM Eastern

Compare

USNA vs. HLF, NATR, NUS, MED, and VERU

Should you buy USANA Health Sciences stock or one of its competitors? MarketBeat compares USANA Health Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with USANA Health Sciences include Herbalife (HLF), Nature's Sunshine Products (NATR), Nu Skin Enterprises (NUS), Medifast (MED), and Veru (VERU). These companies are all part of the "personal products" industry.

How does USANA Health Sciences compare to Herbalife?

USANA Health Sciences (NYSE:USNA) and Herbalife (NYSE:HLF) are both small-cap personal products companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Herbalife has a consensus price target of $17.80, indicating a potential upside of 48.25%. Given Herbalife's stronger consensus rating and higher probable upside, analysts clearly believe Herbalife is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Herbalife	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Herbalife has a net margin of 4.67% compared to USANA Health Sciences' net margin of 0.96%. USANA Health Sciences' return on equity of 6.21% beat Herbalife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Herbalife	4.67%	-41.47%	8.24%

54.3% of USANA Health Sciences shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 5.1% of Herbalife shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Herbalife has higher revenue and earnings than USANA Health Sciences. Herbalife is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.44	$10.76M	$0.47	46.48
Herbalife	$5.04B	0.25	$228.30M	$2.28	5.27

In the previous week, Herbalife had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 5 mentions for Herbalife and 4 mentions for USANA Health Sciences. Herbalife's average media sentiment score of 0.79 beat USANA Health Sciences' score of 0.52 indicating that Herbalife is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Herbalife	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

USANA Health Sciences has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market. Comparatively, Herbalife has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

Summary

Herbalife beats USANA Health Sciences on 12 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Nature's Sunshine Products?

USANA Health Sciences (NYSE:USNA) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Nature's Sunshine Products has a consensus target price of $35.00, indicating a potential upside of 71.32%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nature's Sunshine Products	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Nature's Sunshine Products has a net margin of 4.06% compared to USANA Health Sciences' net margin of 0.96%. Nature's Sunshine Products' return on equity of 14.67% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Nature's Sunshine Products	4.06%	14.67%	9.27%

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, USANA Health Sciences had 3 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 4 mentions for USANA Health Sciences and 1 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.89 beat USANA Health Sciences' score of 0.52 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nature's Sunshine Products	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Nature's Sunshine Products has lower revenue, but higher earnings than USANA Health Sciences. Nature's Sunshine Products is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.44	$10.76M	$0.47	46.48
Nature's Sunshine Products	$480.14M	0.75	$19.52M	$1.10	18.57

USANA Health Sciences has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

Summary

Nature's Sunshine Products beats USANA Health Sciences on 14 of the 17 factors compared between the two stocks.

How does USANA Health Sciences compare to Nu Skin Enterprises?

USANA Health Sciences (NYSE:USNA) and Nu Skin Enterprises (NYSE:NUS) are both small-cap personal products companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Nu Skin Enterprises has higher revenue and earnings than USANA Health Sciences. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.44	$10.76M	$0.47	46.48
Nu Skin Enterprises	$1.49B	0.17	$160.20M	$1.10	4.76

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Nu Skin Enterprises has a net margin of 3.78% compared to USANA Health Sciences' net margin of 0.96%. Nu Skin Enterprises' return on equity of 7.47% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Nu Skin Enterprises	3.78%	7.47%	4.21%

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, USANA Health Sciences had 4 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 4 mentions for USANA Health Sciences and 0 mentions for Nu Skin Enterprises. USANA Health Sciences' average media sentiment score of 0.52 beat Nu Skin Enterprises' score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
USANA Health Sciences	Positive
Nu Skin Enterprises	Neutral

USANA Health Sciences has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

Summary

Nu Skin Enterprises beats USANA Health Sciences on 8 of the 13 factors compared between the two stocks.

How does USANA Health Sciences compare to Medifast?

USANA Health Sciences (NYSE:USNA) and Medifast (NYSE:MED) are both small-cap personal products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

USANA Health Sciences has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.44	$10.76M	$0.47	46.48
Medifast	$385.79M	0.30	-$18.67M	-$1.83	N/A

Medifast has a consensus price target of $12.00, suggesting a potential upside of 17.03%. Given Medifast's stronger consensus rating and higher probable upside, analysts clearly believe Medifast is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Medifast	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 95.5% of Medifast shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 3.7% of Medifast shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

USANA Health Sciences has a net margin of 0.96% compared to Medifast's net margin of -5.78%. USANA Health Sciences' return on equity of 6.21% beat Medifast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Medifast	-5.78%	-4.80%	-3.83%

In the previous week, Medifast had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 5 mentions for Medifast and 4 mentions for USANA Health Sciences. Medifast's average media sentiment score of 1.21 beat USANA Health Sciences' score of 0.52 indicating that Medifast is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medifast	1 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

USANA Health Sciences has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, Medifast has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market.

Summary

USANA Health Sciences beats Medifast on 9 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Veru?

Veru (NASDAQ:VERU) and USANA Health Sciences (NYSE:USNA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

Veru currently has a consensus price target of $23.00, indicating a potential upside of 866.39%. Given Veru's stronger consensus rating and higher possible upside, equities research analysts plainly believe Veru is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veru	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

USANA Health Sciences has a net margin of 0.96% compared to Veru's net margin of 0.00%. USANA Health Sciences' return on equity of 6.21% beat Veru's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veru	N/A	-54.72%	-39.09%
USANA Health Sciences	0.96%	6.21%	4.50%

In the previous week, USANA Health Sciences had 3 more articles in the media than Veru. MarketBeat recorded 4 mentions for USANA Health Sciences and 1 mentions for Veru. Veru's average media sentiment score of 0.94 beat USANA Health Sciences' score of 0.52 indicating that Veru is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veru	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
USANA Health Sciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

USANA Health Sciences has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veru	$16.89M	2.26	-$22.73M	-$0.89	N/A
USANA Health Sciences	$925.26M	0.44	$10.76M	$0.47	46.48

47.2% of Veru shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 14.2% of Veru shares are held by insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Veru has a beta of -1.19, meaning that its stock price is 219% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market.

Summary

USANA Health Sciences beats Veru on 10 of the 16 factors compared between the two stocks.

Get USANA Health Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

USNA vs. The Competition

Export

Metric	USANA Health Sciences	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$418.19M	$3.03B	$6.90B	$23.50B
Dividend Yield	N/A	2.06%	2.67%	4.15%
P/E Ratio	46.48	19.91	27.17	30.91
Price / Sales	0.44	350.00	526.21	19.87
Price / Cash	5.48	57.21	51.46	32.65
Price / Book	0.75	4.26	10.69	4.75
Net Income	$10.76M	$65.46M	$3.59B	$1.07B
7 Day Performance	-1.00%	-3.18%	-2.17%	-0.01%
1 Month Performance	17.97%	0.73%	2.08%	1.62%
1 Year Performance	-28.75%	17.34%	24.68%	16.41%

USANA Health Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
USNA USANA Health Sciences	2.3118 of 5 stars	$21.84 -3.6%	N/A	-27.5%	$418.19M	$925.26M	46.48	1,570
HLF Herbalife	4.317 of 5 stars	$13.11 -0.3%	$17.80 +35.8%	+35.8%	$1.36B	$5.04B	5.75	8,500	News Coverage Positive News
NATR Nature's Sunshine Products	3.4664 of 5 stars	$21.58 +1.5%	$35.00 +62.2%	+40.2%	$374.03M	$480.14M	19.62	850	Positive News
NUS Nu Skin Enterprises	2.3234 of 5 stars	$5.27 +0.8%	N/A	-34.7%	$253.92M	$1.49B	4.79	2,800
MED Medifast	4.0326 of 5 stars	$11.01 +2.7%	$12.00 +9.0%	-22.4%	$119.20M	$385.79M	N/A	870	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:USNA) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

USANA Health Sciences (USNA) Competitors

USNA vs. HLF, NATR, NUS, MED, and VERU

How does USANA Health Sciences compare to Herbalife?

Summary

How does USANA Health Sciences compare to Nature's Sunshine Products?

Summary

How does USANA Health Sciences compare to Nu Skin Enterprises?

Summary

How does USANA Health Sciences compare to Medifast?

Summary

How does USANA Health Sciences compare to Veru?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

USANA Health Sciences (USNA) Competitors

USNA vs. HLF, NATR, NUS, MED, and VERU

How does USANA Health Sciences compare to Herbalife?

Do analysts rate USNA or HLF?

Is USNA or HLF more profitable?

Do insiders and institutionals hold more shares of USNA or HLF?

Which has higher valuation and earnings, USNA or HLF?

Does the media refer more to USNA or HLF?

Which has more risk and volatility, USNA or HLF?

Summary

How does USANA Health Sciences compare to Nature's Sunshine Products?

Do analysts prefer USNA or NATR?

Is USNA or NATR more profitable?

Do insiders and institutionals have more ownership in USNA or NATR?

Does the media refer more to USNA or NATR?

Which has stronger earnings and valuation, USNA or NATR?

Which has more risk & volatility, USNA or NATR?

Summary

How does USANA Health Sciences compare to Nu Skin Enterprises?

Which has stronger earnings & valuation, USNA or NUS?

Do analysts recommend USNA or NUS?

Is USNA or NUS more profitable?

Do insiders & institutionals believe in USNA or NUS?

Does the media refer more to USNA or NUS?

Which has more risk & volatility, USNA or NUS?

Summary

How does USANA Health Sciences compare to Medifast?

Which has preferable valuation & earnings, USNA or MED?

Do analysts prefer USNA or MED?

Do insiders & institutionals hold more shares of USNA or MED?

Is USNA or MED more profitable?

Does the media prefer USNA or MED?

Which has more volatility and risk, USNA or MED?

Summary

How does USANA Health Sciences compare to Veru?

Do analysts prefer VERU or USNA?

Is VERU or USNA more profitable?

Does the media favor VERU or USNA?

Which has preferable valuation & earnings, VERU or USNA?

Do insiders and institutionals hold more shares of VERU or USNA?

Which has more volatility & risk, VERU or USNA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools